Fighting the global diabetes epidemic with Israeli innovation
Diabetes is often associated with injections, but Jerusalem-based Oramed Pharmaceuticals has developed an innovative oral insulin capsule transforming injectable treatments into oral therapies.
Nadav Kidron, CEO of Oramed Pharmaceuticals, shows an insulin pill as he poses for a photo at the company's offices in Jerusalem September 29, 2013. The insulin pill, long desired by diabetes doctors and patients but abandoned as not physically viable, could be available by the end of this decade as(photo credit: BAZ RATNER/REUTERS)ByEYTAN HALONUpdated:
